🇸🇬 Country Profile

Singapore

Affordable medicine reaching Singapore

🇸🇬 $126M
All data from DGCIS India export records (fiscal year, April–March).
$126M
Scale
Singapore's healthcare system receives $126M in Indian pharmaceutical products each year — affordable, quality medicine.
54%
Medicine
A diverse pharmaceutical mix: medicines, medicine ingredients, and surgical & hospital supplies each contributing significantly.
1.4×
Trajectory
Steady growth over the decade: India's pharmaceutical supply to Singapore has expanded 1.4×.
Context
Part of India's pharmaceutical supply network across Asia-Pacific.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Singapore — building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix — FY 2025–26 DGCIS
Medicines $67.5M (53.6%) Medicine Ingredients $47.7M (37.8%) Surgical & Hospital Supplies $6.0M (4.7%) Traditional & Herbal $2.8M (2.2%) Vaccines $2.0M (1.6%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in Singapore Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Singapore: $1.2B across 147 filings (2011-2026).